EMN

Eastman Chemical Company: Q2 2002 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for Eastman Chemical Company for the period ended June 30, 2002. The Company operates in five segments organized into two divisions: Eastman Division (Coatings, Adhesives, Specialty Polymers, and Inks; Performance Chemicals and Intermediates; Specialty Plastics) and Voridian Division (Polymers; Fibers). Effective January 1, 2002, the Company implemented a new divisional structure and adopted SFAS No. 142 regarding goodwill and intangible assets.

Key Financial Metrics

Note: Q2 2001 and 6-month 2001 results included significant nonrecurring charges totaling approximately $306 million related to asset impairments and restructuring.

Material Changes vs. Prior Period

• Profitability Turnaround: The Company reported operating earnings of $81 million in Q2 2002, a significant improvement from an operating loss of $200 million in Q2 2001. This improvement is largely attributable to the absence of the $294 million in asset impairment and restructuring charges recorded in the prior year.
• Revenue Trends: Sales were relatively flat in Q2 2002 compared to Q2 2001. For the first six months, sales declined 4% primarily due to lower selling prices, which were partially offset by higher sales volumes.
• Margin Compression: Gross profit margins decreased (16.4% in Q2 2002 vs. 18.0% in Q2 2001) as selling prices declined more rapidly than raw material costs.
• Accounting Changes: The adoption of SFAS No. 142 resulted in a cumulative effect charge of $18 million in the first quarter of 2002 related to the impairment of certain trademarks. Going forward, goodwill is no longer amortized.
• Debt Management: In April 2002, the Company issued $400 million in 7% notes due 2012 to repay commercial paper and reduce short-term borrowings. Total borrowings decreased from $2,197 million at year-end 2001 to $2,064 million at June 30, 2002.

Guidance, Outlook, and Risks

• Outlook: Management anticipates Q3 2002 operating results (excluding nonrecurring items) to be similar to Q2 2002. The Company expects to generate positive free cash flow and maintain capital spending at or below depreciation and amortization.
• Segment Specifics:
  • Polymers: Expected to face seasonal demand slowing and operational issues in Europe.
  • Fibers: Demand from the Asia Pacific region is expected to decrease in the second half of 2002.
  • CASPI: Expected to benefit from cost reduction efforts and acquisition integration.
• Risks and Contingencies:
  • Sorbates Litigation: The Company is a defendant in 26 antitrust lawsuits regarding price-fixing of sorbates. While 24 have been settled, two remain pending. Management does not believe the outcome will have a material adverse effect on overall financial condition.
  • Market Risks: Exposure to foreign currency exchange rates, raw material costs, and energy prices. The Company utilizes hedging strategies to mitigate these risks.
  • Lease Commitments: A renegotiated operating lease may require $163 million in restricted cash as collateral starting March 2003 if not refinanced, though management deems this remote.

Investor Verification Checklist

• Nonrecurring Items: Verify the exclusion of the $294 million impairment charge in 2001 when comparing year-over-year operating earnings to understand the true operational trend.
• Margin Pressure: Assess the sustainability of gross margins given the trend of selling prices declining faster than raw material costs.
• Debt Structure: Review the impact of the new $400 million long-term debt issuance on future interest expenses compared to the previous commercial paper usage.
• Legal Exposure: Monitor the status of the two remaining pending sorbates antitrust lawsuits for potential future charges.
• Segment Performance: Analyze the specific drivers of the Polymers and Fibers segments, particularly regarding the expected demand slowdown in Asia Pacific and operational issues in Europe.